Changes at the top of commercial units for Gilead and BMS
Christopher Boerner was promoted to lead commercial at BMS, and Laura Hamill joined Gilead from Amgen to head up its commercial operations.
After failure of generic fish oil trial, some caution against read-across to Vascepa study
Amarin's Vascepa trial is set to read out results by the end of September.
Q&A: Matt McNally on the road ahead for Outcome Health and the state of the POC union
Matt McNally, CEO of Outcome Health, shares his thoughts on post-controversy Outcome Health and the overall state of the point-of-care union.
Media buyers form group to advance standards in POC
Among the group's members are media agencies that had pulled healthcare ad spend from the POC channel in the wake of a scandal 10 months ago.
GSW's creative council looks to 'protect ideas, nurture them,' and solve human problems
GSW's creative council met for an honest discussion about the agency-client relationship, the tension between data and emotional connection, industry trends, and creativity in the face of regulation.
